missing translation for 'onlineSavingsMsg'
Learn More

Eslicarbazepine acetate, MedChemExpress

Product Code. 16482196
Encompass_Preferred
Change view
Click to view available options
Quantity:
10 mg
50 mg
100 mg
500 mg
Unit Size:
100mg
10mg
500mg
50mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity Unit Size
16482196 500 mg 500mg
16454457 50 mg 50mg
16428426 100 mg 100mg
16418588 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16482196 Supplier Medchem Express Supplier No. HYB0703
 Restricted Item
Fecha estimada de envoi: 27-11-2026
Add to basket
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

MedChemExpress Eslicarbazepine acetate (BIA 2-093), an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel.

Eslicarbazepine acetate (BIA 2-093), an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel.

Specifications

Chemical Name or Material Eslicarbazepine acetate
Physical Form Solid
CAS 236395-14-5
Color White
Quantity 500 mg
Purity Grade Notes Research
Molecular Formula C17H16N2O3
For Use With (Application) Neuroscience-Neurodegeneration
Synonym BIA 2-093
Solubility Information DMSO : ≥ 100 mg/mL (337.47 mM)
SMILES O=C(N1C2=CC=CC=C2C[C@H](OC(C)=O)C3=CC=CC=C31)N
Molecular Weight (g/mol) 296.32
Formula Weight 296.32
Percent Purity 99.72%
Grade Research
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.